OliX Pharmaceuticals and DynamiCure Partner for RNA-Based ADC Immunotherapy at Korea-US Business Forum

OliX participated in the ‘Korea-US Digital·BioHealth Business Forum’ hosted by the South Korean Ministry of Health and Welfare and Kor...

May 11, 2023 | Thursday | News
Bayer and Bicycle Therapeutics Partner for Targeted Radionuclide Therapies in Oncology

Collaboration will leverage Bicycle Therapeutic’s synthetic peptides for the discovery and development of multiple targeted radioconjugates of the ...

May 11, 2023 | Thursday | News
Lavita AI Raises $5M to Launch Patient-Driven Health Info Marketplace for Life Sciences

-Lavita AI, a next generation AI+Web3 healthcare platform, announced today it has closed a $5M seed financing round, led by Camford Capital, and angel inve...

May 11, 2023 | Thursday | News
HAB Pharma and JVAC Partner to Empower Autistic Children in India

A study conducted by the Indian Council of Medical Research (ICMR) in collaboration with the Ministry of Health and Family Welfare, Government of India, wh...

May 05, 2023 | Friday | News
Rakovina Therapeutics Inc. Announces 2022 Financial Results and Convertible Debenture Financing

Rakovina Therapeutics also announced that it will issue approximately thirty (30) unsecured $50,000 convertible debenture units to a select group of i...

May 02, 2023 | Tuesday | Company results
Could Tumoroids Solve the Problem of High Attrition in Cancer Trials?

There is growing recognition that the experimental model systems used in many cancer research projects, which include 2D cell cultures, patient-derived xen...

May 01, 2023 | Monday | News
The Clinician to participate at Digital Health Festival 2023 in Melbourne

As a sponsor of the event, The Clinician team will be showcasing their healthcare solutions on the exhibition floor at booth F18 and will be hosting a dedi...

May 01, 2023 | Monday | News
Hansa Biopharma, Genethon Collaborate on Imlifidase Pre-Treatment for Crigler-Najjar Syndrome Patients with Anti-AAV Antibodies

The collaboration will, in a clinical study, evaluate the safety and efficacy of Hansa's antibody cleaving enzyme imlifidase as a pre-treatment prior ...

April 28, 2023 | Friday | News
BioCina awarded Grants to develop enabling technologies for manufacture of precision mRNA vaccines

The grant has been awarded by the Australian Government's National Health and Medical Research Council (NHMRC), and will be matched by the South Australian...

April 27, 2023 | Thursday | News
CPC Launches Biopharma's Largest Aseptic Connector

"Biopharma manufacturers continue to press the boundaries of single-use technologies (SUTs) in nearly all of their production processes, including the use ...

April 22, 2023 | Saturday | News
Foundational LCD Covers Select mdx for Prostate Cancer

Michael K. McGarrity, CEO of mdxhealth, commented: “We are pleased to report this very positive and important development for mdxhealth. The quality ...

April 20, 2023 | Thursday | News
JACS Solutions and Baicells to Unveil End-to-End Private 5G Solutions for the Healthcare Industry

Baicells Technologies, a global provider of LTE and 5G network solutions, and JACS Solutions, a global provider of custom connectivity solutions for indust...

April 20, 2023 | Thursday | News
Segmed, NVIDIA, and RadImageNet Kickstart Generative AI Initiative for Synthetic Medical Imaging Data

As part of this initiative, Segmed will offer synthetic medical imaging data on their self-serve medical data curation platform, Segmed Insight. This is in...

April 20, 2023 | Thursday | News
South Korean Biotech, ToolGen Leads the Development of Numerous Cutting-Edge Genome Editing Techniques

The first study presents a new cell-based assay called TAgmentation of Prime Editor sequencing (TAPE-seq) that can predict genome-wide off-target candidate...

April 19, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close